Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: Effect of in vivo treatment with Cl-986, a dual inhibitor of cyclooxygenase and lipoxygenase
S. Gok et al., Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: Effect of in vivo treatment with Cl-986, a dual inhibitor of cyclooxygenase and lipoxygenase, PHARMACOL, 60(1), 2000, pp. 41-46
In this study, coronary perfusion pressure and force of contraction were in
vestigated in isolated hearts removed from arthritic rats by using the Lang
endorff method. A strong coronary vasoconstriction was determined in arthri
tic hearts which was associated with elevated levels of arachidonate 5-lipo
xygenase (5-LOX) products, leukotriene B-4 (LTB4) and LTC4 in coronary effl
uents. In vivo treatment with the dual inhibitor of cyclooxygenase (COX) an
d LOX, CI-986 (2 and 10 mg/kg/day) on days 14-26 following adjuvant injecti
on, prevented the coronary vasoconstriction and the increased production of
LTB4 and LTC4. These results suggest that the coronary vasoconstriction in
the isolated arthritic hearts is associated with an increased activity of
the LOX system and CI-986 could have a preventive effect on constriction of
coronary arteries. Copyright (C) 2000 S. Karger AG, Basel.